vilanterol

Known as: 4-(2-((6-((2-(((2,6-dichlorophenyl)methyl)oxy)ethyl)oxy)hexyl)amino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol, 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol, vilantérol 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2016
Highly Cited
2016
BACKGROUND Chronic obstructive pulmonary disease (COPD) often coexists with cardiovascular disease. Treatments for airflow… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • table 3
Is this relevant?
Highly Cited
2015
Highly Cited
2015
BACKGROUND The short-term benefits of inhaled corticosteroids for patients with chronic obstructive pulmonary disease (COPD) are… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2015
2015
RATIONALE Radiographically confirmed pneumonia risk with inhaled corticosteroid use in chronic obstructive pulmonary disease… (More)
Is this relevant?
Highly Cited
2014
Highly Cited
2014
BACKGROUND Combination long-acting bronchodilator treatment might be more effective than long-acting bronchodilator monotherapy… (More)
Is this relevant?
2014
2014
2014
BACKGROUND Combinations of inhaled long-acting bronchodilator therapies such as muscarinic antagonists and β2-agonists may be… (More)
Is this relevant?
2014
2014
The inhaled corticosteroid fluticasone furoate (FF) and the long-acting β₂ agonist vilanterol (VI) are in development as a… (More)
  • figure 1
  • table 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
Highly Cited
2013
Highly Cited
2013
BACKGROUND Whether the combination of a once-daily inhaled corticosteroid with a once-daily longacting β(2) agonist is more… (More)
Is this relevant?
Highly Cited
2013
Highly Cited
2013
STUDY OBJECTIVE To examine the efficacy and safety of the once-daily, inhaled, long-acting muscarinic antagonist/β2-agonist… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2013
2013
BACKGROUND Once-daily combination treatment is an attractive maintenance therapy for COPD. However, the dose of inhaled… (More)
Is this relevant?